Back to School: How biopharma can reboot drug development. Access exclusive analysis here
In murine cancer xenografts, AV-412 demonstrated anti-tumor effects in epidermal growth
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury